CIM
GILD icon

Contravisory Investment Management’s Gilead Sciences GILD Stock Holding History

Contravisory Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$725K Buy
5,737
+143
+3% +$18.8K 0.13% 124
2026
Q1 		$780K Sell
5,594
-138
-2% -$19.3K 0.16% 110
2025
Q4 		$704K Sell
5,732
-191
-3% -$23.2K 0.14% 113
2025
Q3 		$657K Buy
5,923
+470
+9% +$53.4K 0.13% 119
2025
Q2 		$605K Buy
5,453
+192
+4% +$20.4K 0.12% 115
2025
Q1 		$589K Buy
+5,261
New +$543K 0.12% 115
2023
Q3 		– Sell
-4,624
Closed -$356K – 349
2023
Q2 		$356K Buy
+4,624
New +$369K 0.09% 151
2019
Q1 		– Sell
-200
Closed -$13K – 319
2018
Q4 		$13K Buy
+200
New +$14K 0.01% 244
2018
Q3 		– Sell
-200
Closed -$14K – 320
2018
Q2 		$14K Sell
200
-139
-41% -$9.82K 0.01% 258
2018
Q1 		$26K Hold
339
– – 0.01% 227
2017
Q4 		$24K Buy
339
+139
+70% +$10.6K 0.01% 224
2017
Q3 		$16K Buy
+200
New +$15.3K 0.01% 245
2016
Q1 		– Sell
-128,713
Closed -$13M – 209
2015
Q4 		$13M Sell
128,713
-54,081
-30% -$5.63M 3.47% 1
2015
Q3 		$17.9M Sell
182,794
-5,350
-3% -$594K 4.22% 1
2015
Q2 		$22M Sell
188,144
-15,183
-7% -$1.66M 4.79% 1
2015
Q1 		$20M Sell
203,327
-13,808
-6% -$1.4M 4% 1
2014
Q4 		$20.5M Sell
217,135
-7,925
-4% -$820K 4.14% 1
2014
Q3 		$24M Sell
225,060
-19,513
-8% -$1.91M 5% 1
2014
Q2 		$20.3M Sell
244,573
-22,361
-8% -$1.74M 4.01% 1
2014
Q1 		$18.9M Sell
266,934
-15,856
-6% -$1.24M 3.71% 1
2013
Q4 		$21.2M Sell
282,790
-7,531
-3% -$524K 4.08% 1
2013
Q3 		$18.3M Sell
290,321
-19,705
-6% -$1.18M 3.8% 1
2013
Q2 		$15.9M Buy
+310,026
New +$16.2M 3.53% 1

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Contravisory Investment Management's GILD Position: Q2 2026 in Review

Contravisory Investment Management increased its Gilead Sciences (GILD) stake by 2.6% in Q2 2026, buying an estimated $18.8K and bringing the position to 5,737 shares worth $725K. The position accounts for 0.13% of the portfolio, ranked #124.

Contravisory Investment Management first reported a position in GILD in Q2 2013 and has held it in 23 quarters since. The position peaked at $24M in Q3 2014. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Contravisory Investment Management held 5,737 shares of Gilead Sciences worth $725K as of Q2 2026.
  • Contravisory Investment Management bought 143 Gilead Sciences shares in Q2 2026, an estimated $18.8K.
  • Gilead Sciences made up 0.13% of Contravisory Investment Management's portfolio in Q2 2026, its #124 holding.
  • Contravisory Investment Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 23 quarters since.
  • Contravisory Investment Management's Gilead Sciences position peaked at $24M in Q3 2014.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Contravisory Investment Management's 13F filing for Q2 2026, filed 9 Jul 2026.